What Fueled The Previous Growth In The Continuous Renal Replacement Therapy Market?
The continuous renal replacement therapy market has seen considerable growth due to a variety of factors.
• The continuous renal replacement therapy market has expanded rapidly in recent years. It will increase from $1.57 billion in 2024 to $1.74 billion in 2025, at a compound annual growth rate (CAGR) of 11.3%.
The growth is attributed to the increasing demand for advanced CRRT devices, a rise in the incidence of acute kidney injury, more medical applications, a high prevalence of co-morbidities, and ongoing research and development efforts.
How Does the Forecast Look for the Continuous Renal Replacement Therapy Market?
The continuous renal replacement therapy market is expected to maintain its strong growth trajectory in upcoming years.
• The continuous renal replacement therapy market will reach $2.64 billion by 2029, growing at a CAGR of 10.9%.
Growth is driven by the rising prevalence of chronic kidney diseases, diabetes, ICU admissions, healthcare investments, and pediatric care applications. Trends include rapid technological advancements, new product launches, and innovations in CRRT products.
What Are The Leading Drivers Of Growth In The Continuous Renal Replacement Therapy Market?
The continuous renal replacement therapy market is likely to grow as the incidence of chronic kidney diseases (CKD) rises. CKD, caused by factors like aging, diabetes, and hypertension, is increasing, and CRRT is used to manage acute complications in these patients. The Centers for Disease Control and Prevention reported that more than 35.5 million U.S. adults have CKD, and the prevalence is expected to grow.
How Are The Segments Defined Within The Global Continuous Renal Replacement Therapy Market?
The continuous renal replacement therapy market covered in this report is segmented –
1) By Product: System, Consumables
2) By Therapy: Renal, Non-Renal
3) By Modality: Slow Continuous Ultra-Filtration (SCUF), Continuous Venovenous Hemofiltration (CVVH), Continuous Venovenous Hemodialysis (CVVHD), Continuous Venovenous Hemodiafiltration (CVVHDF)
4) By Age Group: Adults, Pediatrics Or Neonates
5) By End-Users: Hospitals, Ambulatory Care, Homecare
Subsegments:
1) By System: Hemofilters, CRRT Machines, Blood Tubing Sets
2) By Consumables: Dialysate Solutions, Replacement Fluids, Catheters, Bloodline Sets
Pre-Book The Continuous Renal Replacement Therapy Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What New Trends Are Influencing The Continuous Renal Replacement Therapy Market?
Leading companies in the continuous renal replacement therapy market are developing innovative dialysis solutions to improve treatment effectiveness and patient outcomes. This therapy operates continuously, providing gentler care for patients with acute kidney injuries. In January 2023, Peconic Bay Medical Center launched a new renal therapy option to offer a more comfortable and slower process for patients who may not tolerate traditional dialysis.
Who Are the Key Players In The Continuous Renal Replacement Therapy Market?
Major companies operating in the continuous renal replacement therapy market are:
• Medtronic Plc
• Fresenius Medical Care AG & Co. KGaA
• Asahi Kasei Corporation
• Toray Industries Inc.
• Baxter International Inc.
• B. Braun Melsungen AG
• Terumo Corporation
• Nipro Corporation
• NxStage Medical Inc.
• Hillrom Holdings Inc.
• Gambro AB
• JMS Co. Ltd.
• Quanta Dialysis Technologies Ltd.
• Bellco S.r.l.
• Ningbo Tianyi Medical Devices Co. Ltd.
• Cytosorbents Corporation
• Kawasumi Laboratories Inc.
• Medica S.p.A.
• Infomed SA
• Medites Pharma Spol. S.R.O
• Nikkiso Co. Ltd.
• Anjue Medical Equipment Co. Ltd.
• Medcomp Systems Ltd.
What Is The Most Dominant Region In The Continuous Renal Replacement Therapy Market?
North America was the largest region in the continuous renal replacement therapy market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the continuous renal replacement therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
